Status Epilepticus — Adult Management

Key Points

• Treat generalized convulsive seizure activity lasting 5 minutes as status epilepticus.
• Give an adequately dosed benzodiazepine early; underdosing is a common and preventable failure.
• Check glucose immediately but do not delay antiseizure treatment while waiting for routine laboratory results.
• Levetiracetam, fosphenytoin, and valproate are reasonable second-line choices after benzodiazepines.
• Persistent altered consciousness after motor seizure cessation can represent nonconvulsive status.
• Refractory status requires continuous EEG and ICU-level anesthetic therapy.
• Always search for and treat the precipitating cause in parallel with seizure termination.
• Eclampsia and selected toxicologic seizures require cause-specific therapy beyond standard antiseizure drugs.

Algorithm

1. At 0 to 5 minutes, protect the patient from injury, assess airway and breathing, monitor, obtain access, and check glucose.
2. At 5 minutes, give a full-dose benzodiazepine by the fastest reliable route.
3. Repeat the benzodiazepine once when appropriate if convulsions continue while preparing second-line therapy.
4. By roughly 20 minutes, load levetiracetam, fosphenytoin, valproate, or another protocol-approved second-line agent.
5. Obtain targeted labs and imaging and treat reversible causes without interrupting seizure therapy.
6. If seizures persist after adequate second-line therapy, intubate as needed, initiate continuous EEG, and begin refractory-status therapy in ICU care.
7. Confirm electrographic seizure control after paralysis or anesthetic treatment.
8. Develop a maintenance antiseizure regimen and cause-specific follow-up after stabilization.

Clinical Synopsis & Reasoning

Status epilepticus is a time-dependent emergency because prolonged seizure activity becomes harder to terminate and increases the risk of systemic and neurologic complications. Treatment should begin at 5 minutes rather than waiting for the older 30-minute definition. Determine whether apparent ongoing motor activity is epileptic, but do not delay treatment of a convincing generalized convulsive seizure. After convulsions stop, persistent coma can represent a postictal state, sedative effect, metabolic encephalopathy, or nonconvulsive status, making continuous or urgent EEG important when consciousness fails to recover as expected.

Initial evaluation occurs in parallel with treatment. Open the airway, provide oxygen as needed, obtain IV or IO access, monitor ECG and oxygen saturation, and check point-of-care glucose immediately. Correct hypoglycemia without delaying benzodiazepine therapy. Obtain electrolytes, calcium, magnesium, CBC, renal and liver studies, antiseizure medication levels when relevant, pregnancy testing, and toxicology studies based on context. Consider stroke, CNS infection, trauma, medication nonadherence, alcohol withdrawal, toxin exposure, eclampsia, metabolic disturbance, and intracranial mass. Fever, immunocompromise, or meningeal findings may require empiric antimicrobials after stabilization.

Pseudo-status from psychogenic nonepileptic events can mimic convulsive status, but the risk of undertreating true status is substantial. Reassess the diagnosis when multiple appropriately dosed antiseizure drugs fail without expected physiologic features or when video examination suggests a nonepileptic pattern. Neuromuscular blockade can eliminate visible convulsions while electrographic seizures continue, so any paralyzed patient treated for refractory status requires EEG monitoring.

Treatment Strategy & Disposition

Give a full initial benzodiazepine dose rather than repeated small underdoses. Common adult options include lorazepam 0.1 mg/kg IV up to 4 mg, repeat once if needed; midazolam 10 mg IM when IV access is unavailable for adults above typical weight thresholds; or diazepam 0.15 to 0.2 mg/kg IV up to 10 mg. Respiratory support should be available, but fear of benzodiazepine-associated hypoventilation should not produce undertreatment because ongoing convulsive status itself threatens ventilation and outcome.

If seizures persist after adequate benzodiazepine therapy, promptly load a second-line antiseizure medication. Levetiracetam 60 mg/kg IV up to 4.5 g, fosphenytoin 20 mg phenytoin equivalents/kg IV up to 1.5 g PE, and valproate 40 mg/kg IV up to 3 g are widely used evidence-based options with similar efficacy in benzodiazepine-resistant convulsive status. Selection depends on arrhythmia risk, hypotension, hepatic disease, pregnancy potential, drug interactions, and prior therapy. Phenobarbital is an alternative when preferred options are unavailable or clinically appropriate.

Refractory status after benzodiazepine and an adequate second-line load requires neurocritical care, airway management when needed, continuous EEG, and often anesthetic-dose midazolam, propofol, or another ICU agent. Simultaneously treat the cause: magnesium sulfate for eclampsia, pyridoxine for suspected isoniazid poisoning, antibiotics and acyclovir for suspected CNS infection, sodium correction when severe hyponatremia is causal, and reperfusion or neurosurgical therapy for structural lesions when indicated.

Epidemiology / Risk Factors

• Status epilepticus occurs in patients with epilepsy and as the first manifestation of acute neurologic or systemic disease.
• Common adult triggers include antiseizure medication nonadherence, stroke, infection, alcohol withdrawal, metabolic disturbance, and toxic exposure.
• Incidence rises with age and with structural brain disease.
• Mortality depends more on the underlying cause and duration than on seizure activity alone.
• Refractory and super-refractory status carry substantially greater morbidity and mortality.

Investigations

Common Doses (Adult)

Pharmacology

Prognosis / Complications

• Prompt termination of seizures and correction of the underlying cause improve outcome.
• Prolonged duration, older age, anoxic injury, severe infection, and refractory status worsen prognosis.
• Patients can develop aspiration, rhabdomyolysis, hyperthermia, acidosis, arrhythmia, and traumatic injury.
• Postictal cognitive impairment can persist after seizure control and must be distinguished from ongoing nonconvulsive status.
• Long-term antiseizure therapy depends on whether the event was provoked and on recurrence risk.

Patient Education / Counseling

• Review the suspected trigger, including missed medications, alcohol withdrawal, infection, sleep deprivation, or new neurologic disease.
• Provide a clear antiseizure medication schedule and strategies to avoid missed doses.
• Discuss driving and occupational restrictions according to local law and neurologic advice.
• Teach family or caregivers when and how to use prescribed rescue medication for prolonged seizures.
• Call emergency services for a seizure lasting 5 minutes, repeated seizures without recovery, injury, pregnancy, or breathing difficulty.
• Arrange neurology follow-up and ensure the patient understands any new maintenance therapy.

Notes

The American Epilepsy Society treatment framework moves from stabilization to benzodiazepine therapy, then to second-line antiseizure medication, and finally to refractory-status treatment. The key operational principle is speed with adequate dosing.

Treatment continues after visible convulsions stop. Persistent impaired consciousness, medication toxicity, airway complications, and the precipitating disease must still be addressed before disposition.

References

1. American Epilepsy Society Guideline for Prolonged Seizures — Link
2. American Heart Association 2025 Resuscitation Guidelines — Link